Similar humoral immune responses against the SARS-CoV-2 spike protein in HIV and non-HIV individuals after COVID-19
María Martin‐Vicente(Instituto de Salud Carlos III), Salvador Resino(Instituto de Salud Carlos III), Amanda Fernández‐Rodríguez(Instituto de Salud Carlos III), Pablo Ryan, Juan Berenguer(Instituto de Salud Carlos III), Mónica Vázquez(Instituto de Salud Carlos III), Inmaculada Jarrín(Instituto de Salud Carlos III), Marı́a Jesús Pérez-Elı́as(Hospital Universitario Ramón y Cajal), Vicente Más, Isidoro Martínez(Instituto de Salud Carlos III), Cristina Díez(Hospital General Universitario Gregorio Marañón), María Ángeles Jiménez‐Sousa(Instituto de Salud Carlos III), Juan González‐García(Hospital Universitario La Paz), Lucio García‐Fraile(Instituto de Salud Carlos III), Rafael Micán(Hospital Universitario La Paz), María José Muñoz‐Gómez(Instituto de Salud Carlos III), Joaquín Peraire(Hospital General Universitario de Alicante Doctor Balmis), Inés Suárez‐García(Centro de Investigación Biomédica en Red)
Cited by 7
Related Papers
Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies
|The Lancet HIV|2023|506
Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain
|Clinical Microbiology and Infection|2020|423
Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort
|The Lancet HIV|2020|396
Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy
|Annals of Internal Medicine|2020|342